2ϩ -calmodulin-activated serine-threonine phosphatase that is ubiquitously expressed and plays an important role in transducing Ca 2ϩ -dependent signals. Cn is a heterodimer composed of calmodulin binding catalytic subunit A (CnA) and a Ca 2ϩ binding regulatory subunit B (CnB) (10). More than a decade ago, in 1998, Cn was implicated for the first time in regulation of cardiac hypertrophy (9). Since then, the role of Cn as modulator of cardiac hypertrophy has been the subject of several studies using Cn inhibitors or transgenic mice overexpressing active Cn or Cn inhibiting proteins (for review, see Ref. 15). Most of the studies confirm that Cn plays a critical role in the development of pathological hypertrophy (14), but some studies resulted in discrepant results (15). To further understand the role of Cn in the development and normal physiological process in the heart, several groups of investigators generated knockout (KO) animals of specific Cn subunits (2, 16). In mammals, catalytic subunit A is encoded by three genes, and regulatory subunit B is encoded by two genes, from which two catalytic (CnA␣ and CnA␤) and one regulatory (CnB1) are expressed in the heart (10). Although global deletion of CnB leads to embryonic lethality (5), the cardiac-restricted deletion of CnB1, as presented by Schaeffer et al. (12) in last month's issue of the American Journal of Physiology-Heart and Circulatory Physiology, allowed vital mice to be born and further characterizes the role of Cn signaling in the heart development and its function. These mice were initially used and partially characterized in other studies by the same group of investigators (13). In the present paper, mice with cardiac-specific disruption of the gene encoding the Cn regulatory subunit B1 show that Cn is necessary for normal postnatal cardiac growth. Reduced expression of CnB1 results in reduced cardiac biventricular-to-body weight ratios, systolic and diastolic dysfunction, plus increased mortality reaching 100% by 7 mo of age. Interestingly, the dramatic alterations in cardiac function observed at 3 mo of age using both echocardiography and hemodynamic measurements were not accompanied by any histological abnormalities in cardiac myocytes, such as myofibrillar disarray and fibrosis. However, at this time point, the atria showed significant fibrosis and thrombosis, most likely as a result of decreased compliance of ventricles and increased atrial pressure. Moreover, such significant changes in cardiac dynamics were not explained by any significant changes in metabolism, since only mild impairment of fatty acid oxidation in mitochondria isolated from the ventricles was found (12).
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To answer the question of the cellular mechanisms that are responsible for the observed phenotype, the authors focused on whether excitation-contraction coupling is normal or impaired in myocytes isolated from those mice. They found that at relatively low extracellular Ca 2ϩ concentration, shortening of cardiac myocytes and Ca 2ϩ transients was reduced, with no significant changes in sarcoplasmic reticulum Ca 2ϩ load. Shortening was normalized by increasing the extracellular Ca 2ϩ concentration. However, the rates of contraction and relaxation were significantly lower, which correlated with decreased phosphorylation levels of phospholamban (PLB) at Ser16 and Thr17. Since unphosphorylated PLB is known to inhibit the sarcoplasmic reticulum Ca 2ϩ uptake, and its level of phosphorylation correlates with the level of contractility and luisotropy (8) , decreased phosphorylation of PLB observed in CnB1 KO mice may at least partially explain the decreased rates of contraction and relaxation, at both the cellular and whole heart level. Results presented by Schaeffer et al. (12) , however, raise several questions that have not been answered and will require some new studies. How can the lack of Cn expression, a protein that is a phosphatase, explain the reduced level of PLB phosphorylation, and how does this relate to the reduced response to dobutamine in the in situ preparation? These are not known. It has been previously shown that overexpression of Cn resulted in heart failure as a consequence of defects in intercellular myocyte coupling, but not as a result of depressed myocyte contractility and Ca 2ϩ handling (3) . In the present model, lack of Cn expression had the opposite effect on myocyte contractility and Ca 2ϩ transients, which correlates with the whole heart function. However, acute inhibition of Cn increases the Ca 2ϩ transient by increasing PKAmediated phosphorylation of Ca 2ϩ channels and PLB (11), which contradicts data presented in the present paper, and indicates that the effect of Cn on PLB phosphorylation has to be indirect. A possible mechanism may be alterations in the PKA pathway and/or an increase in activity of the phosphatases PP1 and PP2A. PP1 is the major phosphatase responsible for dephosphorylation of PLB, and PP2A is the major phosphatase responsible for dephosphorylation of troponin I (6, 7). During the development of hypertrophy that transitions to heart failure, the level of ␤-adrenergic pathway activation is enhanced. This leads to desensitization and downregulation of ␤-receptors, and therefore the normal response to ␤-agonists is blunted (4), as seen in CnB1 KO mice. Chronic ␤-adrenergic stimulation can also lead to increased PP1 and PP2a activity (1) . Increased activity of PP1 could dephosphorylate PLB, and increased activity of PP2A could dephosphorylate troponin I. Dephosphorylation of both proteins could contribute to the decreased rate of relaxation, and dephosphorylation of PLB would contribute to the depressed contractility, as seen in the present mouse model. Further studies are required to uncover how the lack of Cn results in lethal cardiomyopathy and what the specific molecular mechanisms responsible for this phenotype are.
In summary, previously published data and the data presented in the present paper strongly suggest that Cn plays an important role, not only in pathological cardiac hypertrophy, but also in normal growth of the heart. The cardiac-specific Cn deficiency leads to a lethal cardiomyopathy, which involves proteins involved in excitation-contraction coupling. Therefore, neither too much nor too little Cn is good for the heart.
